BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35121024)

  • 1. Investigating the interference of single nucleotide polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: An in silico approach.
    Mukherjee M; Ghosh S; Goswami S
    Gene; 2022 Apr; 819():146259. PubMed ID: 35121024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a circRNA-miRNA-mRNA network to explore the pathogenesis and treatment of pancreatic ductal adenocarcinoma.
    Xiao Y
    J Cell Biochem; 2020 Jan; 121(1):394-406. PubMed ID: 31232492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
    Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
    Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
    Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
    Felix TF; Lopez Lapa RM; de Carvalho M; Bertoni N; Tokar T; Oliveira RA; M Rodrigues MA; Hasimoto CN; Oliveira WK; Pelafsky L; Spadella CT; Llanos JC; F Silva G; Lam WL; Rogatto SR; Amorim LS; Drigo SA; Carvalho RF; Reis PP
    PLoS One; 2019; 14(5):e0217421. PubMed ID: 31150430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
    Frampton AE; Castellano L; Colombo T; Giovannetti E; Krell J; Jacob J; Pellegrino L; Roca-Alonso L; Funel N; Gall TM; De Giorgio A; Pinho FG; Fulci V; Britton DJ; Ahmad R; Habib NA; Coombes RC; Harding V; Knösel T; Stebbing J; Jiao LR
    Gastroenterology; 2014 Jan; 146(1):268-77.e18. PubMed ID: 24120476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
    Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
    BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.
    Yu Z; Li Z; Jolicoeur N; Zhang L; Fortin Y; Wang E; Wu M; Shen SH
    Nucleic Acids Res; 2007; 35(13):4535-41. PubMed ID: 17584784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma.
    Liu PF; Jiang WH; Han YT; He LF; Zhang HL; Ren H
    Genet Mol Res; 2015 Aug; 14(3):10288-97. PubMed ID: 26345967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-mediated relationships between Cis-SNP genotypes and transcript intensities in lymphocyte cell lines.
    Zhang W; Edwards A; Zhu D; Flemington EK; Deininger P; Zhang K
    PLoS One; 2012; 7(2):e31429. PubMed ID: 22348086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk.
    Mullany LE; Wolff RK; Herrick JS; Buas MF; Slattery ML
    PLoS One; 2015; 10(12):e0143894. PubMed ID: 26630397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C; Qi X
    J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma.
    Venkat S; Tisdale AA; Schwarz JR; Alahmari AA; Maurer HC; Olive KP; Eng KH; Feigin ME
    Genome Res; 2020 Mar; 30(3):347-360. PubMed ID: 32029502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
    Rajamani D; Bhasin MK
    Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3'UTR of ADHD-implicated Genes.
    Abdi A; Zafarpiran M; Farsani ZS
    Cent Nerv Syst Agents Med Chem; 2020; 20(1):58-75. PubMed ID: 31660846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genetic variants in m
    Ying P; Li Y; Yang N; Wang X; Wang H; He H; Li B; Peng X; Zou D; Zhu Y; Zhong R; Miao X; Tian J; Chang J
    Arch Toxicol; 2021 Mar; 95(3):1117-1128. PubMed ID: 33474615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-mediated regulation of gene expression is affected by disease-associated SNPs within the 3'-UTR via altered RNA structure.
    Haas U; Sczakiel G; Laufer SD
    RNA Biol; 2012 Jun; 9(6):924-37. PubMed ID: 22664914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.